# Devyser wins SEK 16.8M tender for genetic testing in Italy

Devyser Diagnostics was awarded a three-year tender by AOU Città Della Salute e della Scienza in Turin, Italy, for NGS genetic tests covering CFTR, BRCA and Thalassemia, with an indicative order value of SEK 16.8 million.

- Type: Contract
- Announced: 2025-02-19
- Where: Turin, Italy
- Value: $1.60M (16.8M SEK)
- Status: announced
- Products: NGS genetic tests for CFTR, BRCA, Thalassemia
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Devyser Diagnostics AB](https://endata.com/companies/88990.md)
- [AOU Città Della Salute e della Scienza](https://endata.com/companies/91590.md) (customer)

## Sources

- [investors.devyser.com](https://investors.devyser.com/en/press/devyser-secures-major-sek-168m-tender-italy-30-growth-2302383), 2026-04-28: "This tender underscores Devyser’s continued excellence in delivering high-quality genetic testing solutions and its commitment to advancing precision medicine."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.